LDL-P & At-Risk Patients

Measurement of LDL particles (LDL-P) is gaining increased recognition among medical providers who manage patients at risk for cardiovascular disease. In this series, hear from LabCorp Medical Director for Cardiovascular Disease, Dr. William Cromwell, as he covers topics related to LDL-P. Learn about a suggested 5-step approach to managing CVD risk in at-risk patients, better understand the discordance between LDL cholesterol and alternative measures of LDL-P and apolipoprotein B, determine if LDL-C is a reliable measure for ASCVD risk in certain at-risk patients, and more!